Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ)

CNY 6.58

(3.95%)

Market Cap (In CNY)

3.33 Billion

Revenue (In CNY)

533.23 Million

Net Income (In CNY)

34.32 Million

Avg. Volume

10.19 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.67-9.3
PE
329.0
EPS
0.02
Beta Value
0.714
ISIN
CNE1000008P1
CUSIP
-
CIK
-
Shares
507510000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Jie Feng
Employee Count
-
Website
https://www.gdjyzy.com.cn
Ipo Date
2007-12-19
Details
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in Mainland China, Taiwan, Hong Kong and Macao, Southeast Asia, Europe, the United States, and internationally. The company provides medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, and gastrointestinal diseases. It offers products in various dosage forms, such as powders, tablets, capsules, granules, and pills. The company sells its products through distribution agencies and sales outlets. Guangdong Jiaying Pharmaceutical Co., Ltd. is based in Meizhou, China.